Drophizine CR Tablets (Levodropropizine)

Adult dose

Adults: Take 1 tablet per dose (equivalent to 90mg of levodropropizine) orally twice daily. This is an extended-release formulation; swallow it whole without splitting or crushing.

This medication should not be used in certain patients. First, individuals allergic to this drug or any of its components should not take it. Patients with increased bronchial mucus secretion or impaired mucociliary function should also avoid this medication. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this drug. Additionally, patients with severe liver dysfunction should also avoid this medication. Since this drug contains lactose, individuals with lactose intolerance or specific genetic metabolic disorders should refrain from taking it. This medication should be administered with caution to patients with severe heart failure, decreased kidney function, the elderly, and children. During treatment, gastrointestinal symptoms such as dyspepsia, nausea, constipation, as well as central nervous system symptoms like drowsiness, headache, and dizziness may occur. Rarely, eyelid edema or orthostatic dizziness may also occur. Care should be taken when driving or operating machinery as drowsiness may occur, especially when taken with alcohol, which can aggravate drowsiness. Since this drug is a prolonged-release formulation, it is advisable to use another formulation that allows for divided dosing in children. Caution should also be exercised when taking this drug with sedatives. Pregnant or nursing women should not take this medication. This drug should be kept out of reach of children and transferring it to another container should be avoided as it may compromise quality.

• nausea
• dyspepsia
• constipation
• drowsiness
• headache
• dizziness
• positional vertigo
• eyelid edema
• increased urinary leukocytes
• elevated ALT

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's efficacy and safety for an extended period.

Appearance

Biconvex prolonged-release tablets with a white to light yellow upper part and a white lower part.

Package unit

30 tablets/bottle, 300 tablets/bottle